WO2014053977A1 - Natural antiseptic solution to be used as teat dip (dipping) during milking for prevention and control of mastitis - Google Patents
Natural antiseptic solution to be used as teat dip (dipping) during milking for prevention and control of mastitis Download PDFInfo
- Publication number
- WO2014053977A1 WO2014053977A1 PCT/IB2013/058940 IB2013058940W WO2014053977A1 WO 2014053977 A1 WO2014053977 A1 WO 2014053977A1 IB 2013058940 W IB2013058940 W IB 2013058940W WO 2014053977 A1 WO2014053977 A1 WO 2014053977A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mastitis
- antiseptic solution
- dipping
- honey
- solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
Definitions
- the present invention relates to the formulation of an antiseptic solution consisting of a propolis extract and honey bee (Apis mellifera) to be used during milking as dipping or teat dip as a prophylactic measure for preventing and controlling mastitis in dairy cows, providing a natural alternative to commercially available products, which occasionally can generate residues in milk and/or cause skin irritation either in the animal or the worker who applies it.
- a propolis extract and honey bee Apis mellifera
- Mastitis is by definition an inflammation of the mammary gland caused mainly by infection of microorganisms and has been considered the greatest impact disease in dairy herds due to its high prevalence and the economic damage it causes. This disease occurs when a pathogenic bacteria enters into the udder, overcomes the cow's immune system, establish an infection and produces an inflammation of the glandular tissue. This inflammation is characterized by increased somatic cell concentration. Mastitis is the disease that causes more economic losses to dairy producers worldwide, with losses that account for 30% of the total cost of all diseases that affect dairy cattle. Annual global losses due to mastitis have been estimated to be 35 billion U.S. dollars.
- the losses caused by this disease can be grouped as follows: reduced production, discarded milk, cost of drugs, cost of veterinary services, extra labor and loss of genetic potential.
- reduced production Considering only milk production in Chile is estimated that annual losses ranged from 162 to 204 million liters of milk due to this disease and that reduction in milk production per lactation in cows with clinical mastitis can arise to 14%, when compared with animals that did not have the disease.
- Mastitis is generally classified as clinical mastitis and sub-clinical mastitis, the former is defined as the inflammation of the udder characterized by visible abnormalities in the milk or in the udder, or both of them, alterations in the composition and appearance of the milk are present; reduced milk production, elevated body temperature of the cow, redness, warmth and swelling of infected quarter(s).
- sub-clinical mastitis is a not visible inflammation of the mammary gland and requires a diagnostic test for detection. This type of mastitis is difficult to detect and cure, because the sick cow is apparently healthy without being so, the mammary gland shows no sign of disease and the produced milk has normal appearance, with no observable changes in its composition or organoleptic characteristics. It is the most dangerous form of mastitis, its frequency is 20-50 times higher than clinical mastitis because no distinct symptoms allowing opportune diagnosis are present, and it also produces alterations in milk composition and reduced production.
- Dipping practice consists of applying an antiseptic solution (usually iodinated) to all teats immediately after removal of the teat cups, with the aim of reducing the microorganisms remaining on the skin and teat orifice at the end of the milking process, thus preventing microorganisms for entering and growing in the teat canal, thereby reducing the risk of intramammary infections.
- an antiseptic solution usually iodinated
- the dipping also leaves residual disinfectant on the teat surface during milking period, during which the teat orifice remains open for at least 30 minutes, thereby preventing bacterial colonization of the teat canal and promoting recovery of lesions, sphincter, and teat canal.
- teat dip with appropriate antiseptic is considered by different researchers the most effective method to prevent new infections in lactating animals.
- chemicals based on chlorine, iodine or other compounds such as chlorhexidine are used for this, its use has negative impact over the environment, and can produce some degree of irritation on the teat skin and in the hands of the milkers.
- the antiseptic solution of the present invention that is made from natural occurring ingredients and composed by propolis and honey, which by its natural characteristics and antibacterial properties can replace chemicals in preventing and controlling mastitis.
- the antiseptic solution described in this invention has the following advantages: does not damage the cows teats, has no negative effects on the hands of the operator, and does not harm the environment, it is also highly effective in preventing and treating sub-clinical mastitis , thereby preventing for cows to become ill, so is an effective prophylactic measure.
- by being a dipping solution protects the teat for a longer time avoiding infection while the teat orifice remains open, which is achieved by the adhesion of the antiseptic solution to the teat surface, given its composition.
- Prior art U.S. Patent Application U.S. 2010322976 discloses a composition including honey and aloe vera useful as a tonic or food supplement for the treatment of mastitis, especially in immunocompromised animals.
- the present invention relates to an antiseptic solution to be used during milking as teat dip or dipping as a prophylactic measure in preventing and controlling mastitis in dairy cows and not for animal consumption as food supplement or tonic.
- the European Patent Application EP1230927 discloses a disinfectant composition for veterinary use in the treatment of mastitis by applying the product in gel form.
- the composition comprises propolis and plant extracts dissolved in water in certain specific percentages.
- said application uses only propolis as active ingredient and a number of essential oils obtained from various plants and applies the product in gel form for the treatment of mastitis and not as dipping for preventing and controlling mastitis.
- the present invention uses a combination of honey and propolis that allows obtaining an effective antiseptic solution for the prevention and/or control of sub-clinical mastitis, applying the product as dipping.
- the International Application WO 8906955 discloses a composition for treating mastitis.
- the active ingredient is propolis (soft propolis) to be mixed with one or more emulsifiers and other additives.
- said application uses only propolis as the active ingredient and it is used to treat mastitis and not as dipping for preventing and controlling mastitis.
- the present invention uses a combination of honey and propolis that allows obtaining an effective antiseptic solution for the prevention and/or control of sub-clinical mastitis.
- the UA 74087 application discloses a composition based on beekeeping products and plant extracts.
- the composition comprises propolis, turpentine, honey, oil carotene, pollen pellets.
- Other ingredients such as excipients (animal fat, beeswax, ethanol, ascorbic acid) are incorporated. Its use is mentioned for treating skin lesions and mastitis in cattle.
- the present invention relates to an antiseptic solution to be used during milking as teat dip or dipping as a prophylactic measure for preventing and controlling mastitis in dairy cattle, and not as treatment for the disease.
- the advantages of the antiseptic solution described herein over other chemicals used as dipping solutions to control mastitis are of great importance in economic terms, but even more important are the physical and chemical properties that would allow to preserve the hygienic quality in addition to avoiding the presence of unwanted residues in the milk.
- the antiseptic solution based on propolis and honey is more efficient than the chemical solutions currently in use and besides it is based on naturally occurring ingredients.
- This invention has been shown to prevent and control sub-clinical mastitis, which is the most difficult to eradicate. Furthermore, prevention of mastitis avoids the use of antibiotics and losses in milk production.
- Figure 1A shows the results of field trials in which the antiseptic solution of the present invention was applied as dipping to cows at farm 1 .
- Each line represents control test results obtained for a particular cow.
- the control test was a somatic cell count carried out fortnightly or at least 1 time per month.
- Figure 1 B shows the results of field tests in which the commercially available composition, whose active ingredient is iodine, is applied as dipping to cows at farm
- Each line represents control test results obtained for a particular cow.
- the control test was a somatic cell count carried out fortnightly or at least 1 time per month.
- Figure 2A shows the results of field trials in which the antiseptic solution of the present invention was applied as dipping to cows at farm 2.
- Each line represents control test results obtained for a particular cow.
- the control test was a somatic cell count carried out fortnightly or at least 1 time per month.
- Figure 2B shows the results of field tests in which the commercially available composition, whose active ingredient is iodine, is applied as dipping to cows at farm
- Each line represents control test results obtained for a particular cow.
- the control test was a somatic cell count carried out fortnightly or at least 1 time per month.
- Figure 3A shows the results of field trials in which the antiseptic solution of the present invention was applied as dipping to cows at farm 3. Each line represents control test results obtained for a particular cow. The control test was a somatic cell count carried out fortnightly or at least 1 time per month.
- Figure 3B shows the results of field tests in which the commercially available composition, whose active ingredient is iodine, is applied as dipping to cows at farm 3. Each line represents control test results obtained for a particular cow. The control test was a somatic cell count carried out fortnightly or at least 1 time per month.
- Figure 4A shows the results of field trials in which the antiseptic solution of the present invention was applied as dipping to cows at farm 4.
- Each line represents control test results obtained for a particular cow.
- the control test was a somatic cell count carried out fortnightly or at least 1 time per month.
- Figure 4B shows the results of field tests in which shows the results of field trials in which the antiseptic solution of the present invention was applied as dipping to cows at farm 4.
- Each line represents control test results obtained for a particular cow.
- the control test was a somatic cell count carried out fortnightly or at least 1 time per month.
- Antiseptic solution is prepared in equals parts or varying the ratios of 2-7% propolis extract to 15-25% (w/v) honey bee Apis mellifera between 1 :5 and 5:1 , both preferably from ulmo (Eucryphia cordifolia) as botanical origin, to be used as dipping solution during milking of dairy herds for the prevention and control of mastitis, as a prophylactic measure.
- 2-7% propolis extract to 15-25% (w/v) honey bee Apis mellifera between 1 :5 and 5:1 , both preferably from ulmo (Eucryphia cordifolia) as botanical origin, to be used as dipping solution during milking of dairy herds for the prevention and control of mastitis, as a prophylactic measure.
- the antiseptic formulation consists of propolis extract and honey; raw materials that should comply with the following properties:
- the obtained extract should preferably be red-orange (CIE system).
- Bioactivity testing and activity verification against major strains of microorganisms causing mastitis should be performed.
- the entire contents of the container should be homogenized, due to the likely heterogeneous active ingredient(s) distribution (flavonoids, hydrogen peroxide, sugars concentration, and pH).
- Antiseptic solution is prepared based on a propolis extract and a honey solution in ratios ranging from 1 :5 to 5:1 , preferably 1 :1 ratio.
- the form of preparation of these components is detailed below:
- Propolis raw material that may have different geographical origin is selected; those brown to red are considered more effective.
- the propolis is dissolved using methanol as solvent and then evaporated to dryness in a rotary evaporator under reduced pressure, in order to obtain the total extract. The extraction of the raw material is repeated three times.
- a solution containing at least 0.5% of flavonoids is prepared in ethyl alcohol/ water 40:60.
- This mixture is allowed to stand for a period between 5 to 24 hours, preferably 8 hours, at room temperature. After that, the mixture is filtered through appropriate means to separate the fat and waxes. The solution obtained is filtered through an appropriate mean to remove fats and waxes, to finally obtain a yellow colored solution.
- a mixture of 15 to 25% (w/v), preferably 20% (w/v), of honey from ulmo (Eucryphia cordifolia) as botanical origin is prepared in distilled water.
- the two solutions thus prepared are mixed at a 1 :5 to 5:1 ratio, preferably 1 :1 , and refiltered, if necessary, to remove fat traces from the mix.
- the product obtained is the antiseptic solution of the present invention developed and tested in the field.
- Antiseptic solution must meet the following quality parameters (Table 1 ) to assure homogeneity of the physicochemical properties of the product.
- An antiseptic solution was prepared according to the present invention, as follows:
- the mixture was allowed to stand for 8 hours at room temperature and then filtered through a Whatman filter paper No. 1.
- the filtrate was evaporated under reduced pressure until a reddish oily concentrate free of solvent was obtained.
- the raw material extraction was repeated three times.
- a solution of 5% concentration (w/v) was prepared with the extract, and it was resuspended in a mixture of ethyl alcohol/water 40% (w/v), this solution was filtered through cotton wool, to finally obtain a yellow colored solution.
- the two solutions, 50 g/L propolis and 200 g/L honey were mixed in a 1 :1 ratio and filtered through cotton wool to remove residual fat from the mixture.
- Antiseptic solution prepared according to Example 1 , was tested "in vitro" against 5 strains of the mayor microorganisms responsible for mastitis: Staphylococcus aureus ATCC 29213 and ATCC 25923, Streptococcus dysgalactiae ABE 11 50, Streptococcus uteris ABEII 46 and Escherichia coli ABEII ATCC 8733.
- TSS trypticase soy agar
- each farm the total number of cows was different and each group was divided into two groups, one of them as a control, using the iodine solution as a teat dip.
- the antiseptic solution of the present invention was used as a teat dip.
- a mammary quarter is a healthy one when somatic cell count of composite milk (all quarters) of a cow does not exceed 100,000 cells/mL, and if it is higher than 200,000 cells/mL the animal exhibits a degree of subclinical mastitis.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Insects & Arthropods (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to the formulation of an antiseptic solution consisting of a propolis extract and honey bee (Apis mellifera) to be used as dipping or teat dip during milking as a prophylactic measure for preventing and controlling mastitis in dairy cows, providing a natural alternative to commercially available products, which occasionally can generate residues in milk and/or cause skin irritation either in the animal or the worker who applies it. The antiseptic solution for preventing sub-clinical mastitis in dairy cows of the present invention comprises a mixture of propolis extract and honey solution in ratios ranging from 1:5 to 5:1.
Description
NATURAL ANTISEPTIC SOLUTION TO BE USED AS TEAT DIP (DIPPING) DURING MILKING FOR PREVENTION AND CONTROL OF MASTITIS
SPECIFICATION OBJECT OF THE INVENTION
The present invention relates to the formulation of an antiseptic solution consisting of a propolis extract and honey bee (Apis mellifera) to be used during milking as dipping or teat dip as a prophylactic measure for preventing and controlling mastitis in dairy cows, providing a natural alternative to commercially available products, which occasionally can generate residues in milk and/or cause skin irritation either in the animal or the worker who applies it.
BACKGROUND OF THE INVENTION
Mastitis is by definition an inflammation of the mammary gland caused mainly by infection of microorganisms and has been considered the greatest impact disease in dairy herds due to its high prevalence and the economic damage it causes. This disease occurs when a pathogenic bacteria enters into the udder, overcomes the cow's immune system, establish an infection and produces an inflammation of the glandular tissue. This inflammation is characterized by increased somatic cell concentration. Mastitis is the disease that causes more economic losses to dairy producers worldwide, with losses that account for 30% of the total cost of all diseases that affect dairy cattle. Annual global losses due to mastitis have been estimated to be 35 billion U.S. dollars. The losses caused by this disease can be grouped as follows: reduced production, discarded milk, cost of drugs, cost of veterinary services, extra labor and loss of genetic potential. Considering only milk production in Chile is estimated that annual losses ranged from 162 to 204 million liters of milk due to this disease and that reduction in milk production per lactation in cows with clinical mastitis can arise to 14%, when compared with animals that did not have the disease.
Mastitis is generally classified as clinical mastitis and sub-clinical mastitis, the former is defined as the inflammation of the udder characterized by visible abnormalities in the milk or in the udder, or both of them, alterations in the composition and appearance of the milk are present; reduced milk production, elevated body temperature of the cow,
redness, warmth and swelling of infected quarter(s). While sub-clinical mastitis is a not visible inflammation of the mammary gland and requires a diagnostic test for detection. This type of mastitis is difficult to detect and cure, because the sick cow is apparently healthy without being so, the mammary gland shows no sign of disease and the produced milk has normal appearance, with no observable changes in its composition or organoleptic characteristics. It is the most dangerous form of mastitis, its frequency is 20-50 times higher than clinical mastitis because no distinct symptoms allowing opportune diagnosis are present, and it also produces alterations in milk composition and reduced production.
Among the measures that have given best results in the control of mastitis or reduction of somatic cells is the teat dip or dipping. Dipping practice consists of applying an antiseptic solution (usually iodinated) to all teats immediately after removal of the teat cups, with the aim of reducing the microorganisms remaining on the skin and teat orifice at the end of the milking process, thus preventing microorganisms for entering and growing in the teat canal, thereby reducing the risk of intramammary infections. The dipping also leaves residual disinfectant on the teat surface during milking period, during which the teat orifice remains open for at least 30 minutes, thereby preventing bacterial colonization of the teat canal and promoting recovery of lesions, sphincter, and teat canal.
After milking, teat dip with appropriate antiseptic is considered by different researchers the most effective method to prevent new infections in lactating animals. However, chemicals based on chlorine, iodine or other compounds such as chlorhexidine are used for this, its use has negative impact over the environment, and can produce some degree of irritation on the teat skin and in the hands of the milkers.
For this reason arise the need for alternatives, such as the antiseptic solution of the present invention that is made from natural occurring ingredients and composed by propolis and honey, which by its natural characteristics and antibacterial properties can replace chemicals in preventing and controlling mastitis. The antiseptic solution described in this invention has the following advantages: does not damage the cows teats, has no negative effects on the hands of the operator, and does not harm the environment, it is also highly effective in preventing and treating sub-clinical mastitis , thereby preventing for cows to become ill, so is an effective prophylactic measure. On the other hand, by being a dipping solution protects the teat for a longer time avoiding
infection while the teat orifice remains open, which is achieved by the adhesion of the antiseptic solution to the teat surface, given its composition.
Prior art U.S. Patent Application U.S. 2010322976 discloses a composition including honey and aloe vera useful as a tonic or food supplement for the treatment of mastitis, especially in immunocompromised animals. In contrast to what is disclosed in said document, the present invention relates to an antiseptic solution to be used during milking as teat dip or dipping as a prophylactic measure in preventing and controlling mastitis in dairy cows and not for animal consumption as food supplement or tonic.
The European Patent Application EP1230927 discloses a disinfectant composition for veterinary use in the treatment of mastitis by applying the product in gel form. The composition comprises propolis and plant extracts dissolved in water in certain specific percentages. In contrast to the present invention, said application uses only propolis as active ingredient and a number of essential oils obtained from various plants and applies the product in gel form for the treatment of mastitis and not as dipping for preventing and controlling mastitis. The present invention uses a combination of honey and propolis that allows obtaining an effective antiseptic solution for the prevention and/or control of sub-clinical mastitis, applying the product as dipping.
The International Application WO 8906955 discloses a composition for treating mastitis. The active ingredient is propolis (soft propolis) to be mixed with one or more emulsifiers and other additives. In contrast with the present invention, said application uses only propolis as the active ingredient and it is used to treat mastitis and not as dipping for preventing and controlling mastitis. The present invention uses a combination of honey and propolis that allows obtaining an effective antiseptic solution for the prevention and/or control of sub-clinical mastitis.
The UA 74087 application discloses a composition based on beekeeping products and plant extracts. The composition comprises propolis, turpentine, honey, oil carotene, pollen pellets. Other ingredients such as excipients (animal fat, beeswax, ethanol, ascorbic acid) are incorporated. Its use is mentioned for treating skin lesions and mastitis in cattle. In contrast with what is disclosed in said document, the present invention relates to an antiseptic solution to be used during milking as teat dip or dipping as a prophylactic measure for preventing and controlling mastitis in dairy cattle, and not as treatment for the disease.
The advantages of the antiseptic solution described herein over other chemicals used as dipping solutions to control mastitis, are of great importance in economic terms, but even more important are the physical and chemical properties that would allow to preserve the hygienic quality in addition to avoiding the presence of unwanted residues in the milk. From the technical standpoint, the antiseptic solution based on propolis and honey is more efficient than the chemical solutions currently in use and besides it is based on naturally occurring ingredients. This invention has been shown to prevent and control sub-clinical mastitis, which is the most difficult to eradicate. Furthermore, prevention of mastitis avoids the use of antibiotics and losses in milk production.
BRIEF DESCRIPTION OF THE FIGURES
Figure 1A shows the results of field trials in which the antiseptic solution of the present invention was applied as dipping to cows at farm 1 . Each line represents control test results obtained for a particular cow. The control test was a somatic cell count carried out fortnightly or at least 1 time per month.
Figure 1 B shows the results of field tests in which the commercially available composition, whose active ingredient is iodine, is applied as dipping to cows at farm
1 . Each line represents control test results obtained for a particular cow. The control test was a somatic cell count carried out fortnightly or at least 1 time per month.
Figure 2A shows the results of field trials in which the antiseptic solution of the present invention was applied as dipping to cows at farm 2. Each line represents control test results obtained for a particular cow. The control test was a somatic cell count carried out fortnightly or at least 1 time per month.
Figure 2B shows the results of field tests in which the commercially available composition, whose active ingredient is iodine, is applied as dipping to cows at farm
2. Each line represents control test results obtained for a particular cow. The control test was a somatic cell count carried out fortnightly or at least 1 time per month.
Figure 3A shows the results of field trials in which the antiseptic solution of the present invention was applied as dipping to cows at farm 3. Each line represents control test results obtained for a particular cow. The control test was a somatic cell count carried out fortnightly or at least 1 time per month.
Figure 3B shows the results of field tests in which the commercially available composition, whose active ingredient is iodine, is applied as dipping to cows at farm 3. Each line represents control test results obtained for a particular cow. The control test was a somatic cell count carried out fortnightly or at least 1 time per month.
Figure 4A shows the results of field trials in which the antiseptic solution of the present invention was applied as dipping to cows at farm 4. Each line represents control test results obtained for a particular cow. The control test was a somatic cell count carried out fortnightly or at least 1 time per month.
Figure 4B shows the results of field tests in which shows the results of field trials in which the antiseptic solution of the present invention was applied as dipping to cows at farm 4. Each line represents control test results obtained for a particular cow. The control test was a somatic cell count carried out fortnightly or at least 1 time per month.
DETAILED DESCRIPTION OF THE INVENTION.
Antiseptic solution is prepared in equals parts or varying the ratios of 2-7% propolis extract to 15-25% (w/v) honey bee Apis mellifera between 1 :5 and 5:1 , both preferably from ulmo (Eucryphia cordifolia) as botanical origin, to be used as dipping solution during milking of dairy herds for the prevention and control of mastitis, as a prophylactic measure.
The antiseptic formulation consists of propolis extract and honey; raw materials that should comply with the following properties:
. PROPOLIS:
L it should have been harvested through mesh, a technique for obtaining a product without solid impurities such as wood cuttings, pieces of wood, paints and others.
2. The obtained extract should preferably be red-orange (CIE system).
3. It should have at least 10% of total flavonoids.
4. It should contain at least the following polyphenols and/or flavonoids: apigenin, chrysin, galangin, kaempferol and pinocembrin.
5. It should be antibiotic free.
6. Bioactivity testing and activity verification against major strains of microorganisms causing mastitis (Staphylococcus aureus ATCC 29213 and
ATCC 25923, Streptococcus dysgalactiae ABEII50 , Streptococcus uberis ABEII- 46), should be performed.
. HONEY:
1 . Using annual season honey (fresh), preferably from ulmo (Eucryphia cord i folia).
2. Prior to preparation of the honey solution, the entire contents of the container should be homogenized, due to the likely heterogeneous active ingredient(s) distribution (flavonoids, hydrogen peroxide, sugars concentration, and pH).
3. Bioactivity testing and activity verification against Escherichia coli and at least against two of the microorganisms of highest incidence on mastitis, noted above, should be performed.
4. Using honey which has not undergone heat treatment above 40°C and determine the presence of hydroxymethylfurfural (HMF), not exceeding the provisions of Chilean Standard (40 meq/kg)
5. It should be antibiotic free.
METHOD OF PREPARATION OF THE ANTISEPTIC SOLUTION.
Antiseptic solution is prepared based on a propolis extract and a honey solution in ratios ranging from 1 :5 to 5:1 , preferably 1 :1 ratio. The form of preparation of these components is detailed below:
• Propolis extract:
Propolis raw material that may have different geographical origin is selected; those brown to red are considered more effective. The propolis is dissolved using methanol as solvent and then evaporated to dryness in a rotary evaporator under reduced pressure, in order to obtain the total extract. The extraction of the raw material is repeated three times.
Depending on total flavonoids content, a solution containing at least 0.5% of flavonoids is prepared in ethyl alcohol/ water 40:60.
This mixture is allowed to stand for a period between 5 to 24 hours, preferably 8 hours, at room temperature. After that, the mixture is filtered through appropriate means to separate the fat and waxes.
The solution obtained is filtered through an appropriate mean to remove fats and waxes, to finally obtain a yellow colored solution.
• Honey solution:
A mixture of 15 to 25% (w/v), preferably 20% (w/v), of honey from ulmo (Eucryphia cordifolia) as botanical origin is prepared in distilled water.
The two solutions thus prepared (the solution of propolis extract and honey aqueous solution) are mixed at a 1 :5 to 5:1 ratio, preferably 1 :1 , and refiltered, if necessary, to remove fat traces from the mix. The product obtained is the antiseptic solution of the present invention developed and tested in the field.
Antiseptic solution must meet the following quality parameters (Table 1 ) to assure homogeneity of the physicochemical properties of the product.
Table 1. Quality parameters of the mixture obtained as antiseptic solution.
The following are exemplary applications that better illustrate and explain the invention, and are not to be taken in any way as limiting the scope and application of the present invention.
EXAMPLES
EXAMPLE 1
Preparation of the antiseptic solution.
An antiseptic solution was prepared according to the present invention, as follows:
• Propolis extract:
Chilean propolis from different geographical origins were obtained, selecting those brown to red.
500 grams of the selected raw propolis was put in a glass vessel and was suspended in 1 L of ethyl alcohol.
The mixture was allowed to stand for 8 hours at room temperature and then filtered through a Whatman filter paper No. 1. The filtrate was evaporated under reduced pressure until a reddish oily concentrate free of solvent was obtained. The raw material extraction was repeated three times.
A solution of 5% concentration (w/v) was prepared with the extract, and it was resuspended in a mixture of ethyl alcohol/water 40% (w/v), this solution was filtered through cotton wool, to finally obtain a yellow colored solution.
• Honey solution:
200 g were dissolved up to one liter solution with distilled water.
The two solutions, 50 g/L propolis and 200 g/L honey were mixed in a 1 :1 ratio and filtered through cotton wool to remove residual fat from the mixture.
EXAMPLE 2
Determination of "in vitro" activity of the antiseptic solution of the invention
Antiseptic solution, prepared according to Example 1 , was tested "in vitro" against 5 strains of the mayor microorganisms responsible for mastitis: Staphylococcus aureus ATCC 29213 and ATCC 25923, Streptococcus dysgalactiae ABE 11 50, Streptococcus uteris ABEII 46 and Escherichia coli ABEII ATCC 8733.
For "in vitro" tests trypticase soy agar (TSS) was used as culture medium, which was coated on a 14 cm petri dish, finally obtaining a 105 CFU/mL lawn for each of the
strains under study. After the lawn was solidified, holes were punched with a diameter of 7.58 mm each one, forming wells over which 50 L of sample was put.
Subsequently, inhibition halos formed around each well were measured with a digital caliper, the average results appear in Table 2.
The results presented in Table 2 clearly show the inhibitory effect of the antiseptic solution against the strains used, compared to the iodine solution (commercial solution).
Table 2. Average results of antibacterial activity inhibition halos of antiseptic solution and iodine solution over causing mastitis strains.
According to the results shown in Table 2, it can be concluded that the antiseptic solution has a broad spectrum of activity against certified strains, even against £. co//, strain responsible for environmental mastitis and which exhibits higher inhibitory activity compared with iodine solution. Example 3
Determination of the activity in the field for antiseptic solution of the present invention in dairy cows We conducted a field trial between April 201 1 and April 2012, in Chile, in which the antiseptic solution was applied as a teat dip (dipping) in 4 groups of cows randomly selected, located in 4 dairy farms. To compare the effect of the results, the commercial solution (iodine) was applied to 4 groups of cows (randomly selected) in parallel, which
is commonly used in dairy farms and is applied to the cows teats at the at the end of milking process, to prevent mastitis.
In each farm, the total number of cows was different and each group was divided into two groups, one of them as a control, using the iodine solution as a teat dip. In the second group the antiseptic solution of the present invention was used as a teat dip.
To measure the effect of the batches of cows under study on the prevention and control of mastitis, biweekly or monthly counting of somatic cells in milk from each cow was used as a parameter for evaluating and comparing.
The results showed that the values of somatic cell count registered in the cows under study in all farms allow us to assure that with the antiseptic solution of the present invention are obtained better results than with the iodine solution, keeping count levels below which have been established for cows as free of sub-clinical mastitis in literature, <200,000 cells/mL. An example of these results is shown by comparing the evolution and behavior of somatic cell counts from cows that were subjected to the antiseptic solution v/s cows subjected to iodine solution in the same field (Figures 1-4 A and B). To confirm the above mentioned effect, according to the results of average somatic cell counts per cow, we proceeded to the statistical analysis of the data, which was performed by the "t-student" test for two samples, assuming unequal variances, for all farms in the trial. The total analysis of the cows results in statistically significant differences in the application of dipping solutions for sub-clinical mastitis treatment, with the antiseptic solution application showing better results (Table 3). Furthermore, the antiseptic solution proved to have greater adherence to the teat surface, remaining in this for a longer period of time.
However, when using both solutions as teat dip an increase in the number of somatic cells in the 20 biweekly observations was noticed, which is explained by the normal increase in these cells with advancing lactation, milking frequency, age, nutrition, in addition to the degree of initial mastitis and stress level of the animals under study.
Therefore, it has been suggested that a mammary quarter is a healthy one when somatic cell count of composite milk (all quarters) of a cow does not exceed 100,000
cells/mL, and if it is higher than 200,000 cells/mL the animal exhibits a degree of subclinical mastitis.
Table 3. Field analysis results for all fields and cows under study.
Claims
1 . Antiseptic solutions for prevention of sub-clinical mastitis in dairy cows, CHARACTERIZED in that it comprises a mixture of propolis extract and honey solution in ratios ranging from 1 :5 to 5:1.
2. Antiseptic solution according to claim 1 , characterized in that the best mixing ratio is 1 :1 .
3. Antiseptic solution according to claim 1 , CHARACTERIZED in that the propolis extract is prepared between 2-7% (w/v), and the honey solution is prepared between 15-25% (w/v).
4. Antiseptic solution according to claim 1, CHARACTERIZED in that the propolis extract is used at 5% (w/v) and the honey solution at 20% (w/v).
5. Antiseptic solution according to claim 1 , CHARACTERIZED in that the propolis extract is obtained using ethyl alcohol as a solvent, or methyl alcohol, or isopropyl alcohol, or acetone, or ethyl acetate, aqueous solutions or mixtures of such solvents.
6. Antiseptic solution according to claim 1, CHARACTERIZED in that the solvent mixture used is preferably ethyl alcohol/water.
7. Use of antiseptic solution according to claims 1 to 6, CHARACTERIZED in that it serves as a prophylactic measure in the prevention and control of subclinical mastitis in dairy cows and is applied as a teat dip or dipping.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2012002768A CL2012002768A1 (en) | 2012-10-02 | 2012-10-02 | Antiseptic solution for prevention of subclinical mastitis in dairy cows comprising a mixture of propolis and solution of honey bees in proportions from 1: 5 to 5: 1, use of the antiseptic solution because it serves for the prophylaxis, prevention and control of subclinical mastitis of dairy cows. |
CL2768-2012 | 2012-10-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014053977A1 true WO2014053977A1 (en) | 2014-04-10 |
Family
ID=50434424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2013/058940 WO2014053977A1 (en) | 2012-10-02 | 2013-09-27 | Natural antiseptic solution to be used as teat dip (dipping) during milking for prevention and control of mastitis |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR092733A1 (en) |
CL (1) | CL2012002768A1 (en) |
WO (1) | WO2014053977A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2743879C1 (en) * | 2020-04-14 | 2021-03-01 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Вятская государственная сельскохозяйственная академия" (ФГБОУ ВО Вятская ГСХА) | Method for prevention of udder inflammation in cows in interlactation period and after delivery |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989006955A1 (en) | 1988-02-08 | 1989-08-10 | Unipharmart | Process for manufacturing veterinary products being suitable particularly for treatment of mastitis and the product thus obtained |
EP1230927A1 (en) | 2001-02-12 | 2002-08-14 | Allegrini S.p.a. | Phyto-derivative disinfectant solution for veterinary use in the endo-mammary anti-mastitis treatment of milk-producing animals |
UA74087C2 (en) | 2004-03-03 | 2005-10-17 | Володимир Олексійович Постоєнко | Veterinary remedy comprising products of beekeeping and herbal components |
WO2008097109A1 (en) * | 2007-02-05 | 2008-08-14 | Kuldeep Sharma | Tonic and food supplement comprising aloe vera and honey |
BRPI0903699A2 (en) * | 2009-07-30 | 2011-04-19 | Da Silva Zenaldo Porfirio | red propolis and melito for bovine mastitis treatment |
KR20110092509A (en) * | 2010-02-09 | 2011-08-18 | 주식회사 제일바이오 | Composition for treating bovine mastitis |
-
2012
- 2012-10-02 CL CL2012002768A patent/CL2012002768A1/en unknown
-
2013
- 2013-09-27 WO PCT/IB2013/058940 patent/WO2014053977A1/en active Application Filing
- 2013-09-27 AR ARP130103507A patent/AR092733A1/en unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989006955A1 (en) | 1988-02-08 | 1989-08-10 | Unipharmart | Process for manufacturing veterinary products being suitable particularly for treatment of mastitis and the product thus obtained |
EP1230927A1 (en) | 2001-02-12 | 2002-08-14 | Allegrini S.p.a. | Phyto-derivative disinfectant solution for veterinary use in the endo-mammary anti-mastitis treatment of milk-producing animals |
UA74087C2 (en) | 2004-03-03 | 2005-10-17 | Володимир Олексійович Постоєнко | Veterinary remedy comprising products of beekeeping and herbal components |
WO2008097109A1 (en) * | 2007-02-05 | 2008-08-14 | Kuldeep Sharma | Tonic and food supplement comprising aloe vera and honey |
US20100322976A1 (en) | 2007-02-05 | 2010-12-23 | Kuldeep Sharma | Tonic and food supplement comprising aloe vera and honey |
BRPI0903699A2 (en) * | 2009-07-30 | 2011-04-19 | Da Silva Zenaldo Porfirio | red propolis and melito for bovine mastitis treatment |
KR20110092509A (en) * | 2010-02-09 | 2011-08-18 | 주식회사 제일바이오 | Composition for treating bovine mastitis |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Week 201171, Derwent World Patents Index; AN 2011-H26170, XP002719694 * |
DATABASE WPI Week 201236, Derwent World Patents Index; AN 2011-L47943, XP002719693 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2743879C1 (en) * | 2020-04-14 | 2021-03-01 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Вятская государственная сельскохозяйственная академия" (ФГБОУ ВО Вятская ГСХА) | Method for prevention of udder inflammation in cows in interlactation period and after delivery |
Also Published As
Publication number | Publication date |
---|---|
CL2012002768A1 (en) | 2013-06-21 |
AR092733A1 (en) | 2015-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Koba et al. | Prevention of mastitis in dairy cows on industrial farms | |
Hamadani et al. | Bovine mastitis-A disease of serious concern for dairy farmers | |
Aamer et al. | Minimum Inhibitory and Bactericidal Concentrations (MIC and MBC) of Honey and Bee Propolis against Multi-Drug Resistant (MDR) Staphylococcus sp | |
ZHANG et al. | Evaluation of a povidone-iodine and chitosan-based barrier teat dip in the prevention of mastitis in dairy cows | |
CN104257684A (en) | Medicated bath liniment for cow nipples and preparation method of medicated bath liniment | |
Acharya et al. | Bovine mastitis: Causes and phytoremedies | |
Ndhlovu et al. | In vitro efficacy of extracts from plants used by small-holder farmers in the treatment of dermatophilosis in cattle | |
WO2014053977A1 (en) | Natural antiseptic solution to be used as teat dip (dipping) during milking for prevention and control of mastitis | |
CN110339121A (en) | Bactericidal composition and the preparation method and application thereof | |
LV15071B (en) | Composition for treatment of subclinical mastitis in cows | |
Laloučková et al. | In vitro antimicrobial effect of palm oils rich in medium-chain fatty acids against mastitis-causing Gram-positive bacteria. | |
KR101828563B1 (en) | A composition for prevention and treatment of foulbrood | |
Waghmare et al. | Application of herbal teat dip Mastidip liquid in subclinically mastitic animals and its role in further prevention of mastitis | |
US20210128695A1 (en) | Ovotransferrin treatment for the reproductive tract | |
KR102254424B1 (en) | Antimicrobial composition comprising the extract of sageretia thea | |
WO2017144925A1 (en) | Topical composition for treatment and/or prophilaxis of mastitis and/or edema | |
GB2589856A (en) | Composition for use of reducing SCC and subsequent mastitis in dairy cows | |
Patil et al. | Shivi Maini.“Mastidip Liquid” a herbal post milking teat dip for prevention and control of subclinical mastitis in bovines | |
CN104605160B (en) | A kind of compositions preventing and treating sow puerperal endometritis and application thereof | |
Komala et al. | THE EFFECTIVENESS OF APPLICATIONS OF BETEL (Piper Betel Linn.) LEAF EXTRACT AND BACTERIOCIN FOR TEAT DIPPING DURING MILKING HANDLING IN INDONESIAN DAIRY FARMING | |
KR102434892B1 (en) | Antiviral feed composition containing plum extract as an active ingredient | |
Suselowati et al. | Evaluation of herbal antiseptic red teak leaf extract (Tectona grandis Linn. F.) as teat gel for dairy cow | |
KR20100089394A (en) | A composition comprising the extract of galla rhois as an active ingredient for preventing and treating dairy cattle mastitis | |
Pereira | The impact of the topical exposure to Cytinus hypocistis extract on fungi of medical relevancy and in Staphylococcus aureus as a potential alternative treatment for bovine mastitis | |
Singh et al. | Study the prevalence of S. aureus in subclinical mastitis and their antibiogram in buffaloes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13818794 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 26.11.2015) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13818794 Country of ref document: EP Kind code of ref document: A1 |